Back
HFA Premium Access

IRONMAN: Effect of intravenous iron according to age

Session: Late breaking clinical trials
Topic: Pharmacotherapy
Speaker: Professor I. Squire (Leicester, GB)
Event: Heart Failure 2023

Congress Presentation

Add to my library

Like

About the speaker

Professor Iain B Squire

University of Leicester, Leicester (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

5 more presentations in this session

Dapagliflozin and PAD in HF

Speaker: Doctor J. Butt (Copenhagen, DK)

Access
Slides
Video
Like
Thumbnail

FINEARTS-HF: Design and Baseline Characteristics

Speaker: Professor S. Solomon (Boston, US)

Access
Slides
Video
Like
Thumbnail

Reasons for hospitalisation and mode of death for patients with heart failure and iron deficiency in the IRONMAN randomized trial.

Speaker: Professor J. Cleland (Glasgow, GB)

Access
Slides
Video
Like
Thumbnail

IRONMAN: anaemia, iron deficiency and quality of life in heart failure and its response to IV iron

Speaker: Professor P. Kalra (Portsmouth, GB)

Access
Slides
Video
Like
Thumbnail

IRONMAN: Which marker of iron deficiency best predicts response to intravenous iron in patients with heart failure?

Speaker: Professor J. Cleland (Glasgow, GB)

Access
Slides
Video
Like
Thumbnail

Access the full session

Late breaking clinical trials

Speakers: Professor I. Squire, Doctor J. Butt, Professor S. Solomon, Professor J. Cleland, Professor P. Kalra...
Access
Video
Like
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources